Explore STADA

Sustainability

As a pharmaceutical and healthcare company, STADA takes responsibility for the safety of its products and the well-being of patients. In our 2024 Sustainability Report, we outline our approach to sustainability, share our ESG commitments, and report on the progress we have made.

Diversity & Inclusion

Our culture thrives on empowering our people to bring forward their unique and diverse experiences. Thought leadership article by Simone Berger, CPO.

Trusted Partner

Central to STADA's commitment to caring for people's health through consumer healthcare products, specialty medicines and generics are close partnerships to improve health globally.

Global STADA+ Day

Thousands of our employees worldwide joined in as the best STADA+ cases were recognized in a "Shark Tank"-style event.

Parkinson’s Disease

Raising awareness for the world’s second most common neurodegenerative disease. By 2050, 25 million people could be affected. Parkinson’s goes beyond movement – it impacts everyday life and mental health. At STADA, we stand for progress, solidarity and hope.

Three-pillar Strategy

The company focuses on consumer healthcare products, generics and speciality medicines. 

Your opportunity for success with STADA

We are looking for qualified employees who drive our company forward with their specialist knowledge and commitment. We offer appealing conditions with diverse and exciting tasks as well as good career prospects and a motivating working environment.

Growth mindset: Our people are our ambassadors

Follow us on LinkedIn

Latest news

STADA’s growth journey continues in 2024
07/03/2025
STADA sets course for the future - experienced healthcare manager Andreas Fibig to become Chairman of the Board
09/01/2025
STADA welcomes Ingo Schachel as Head of Investor Relations
04/12/2024
New STADA facility in Romania for sustainable medicines supply in Europe
31/10/2024
EMA accepts Marketing Authorization Applications for AVT03, a Proposed Denosumab Biosimilar
10/10/2024
STADA continues strong growth journey in the first half of 2024
28/08/2024
STADA receives European Commission approval to expand label and patient group for IgA Nephropathy orphan medicine
26/07/2024
STADA has launched Europe’s first approved ustekinumab biosimilar in multiple European countries
22/07/2024
STADA Health Report 2024
24/06/2024

STADA Voices

Play
Miguel Pagan Fernandez
Chief Technical Officer (CTO)
Play
Frank Staud
Executive Vice President Global Communications & Branding
Play
Volker Sydow
Executive Vice President Global Consumer Healthcare
Play
Stéphane Jacqmin
Executive Vice President Emerging Markets
Play
Christoph Dengler
Executive Vice President Global Legal
Play
Christos Gallis
Head of Eastern Europe

Consumer Healthcare products

STADA is the fourth-largest consumer healthcare company in Europe and markets products internationally in all relevant healthcare categories. The most significant drivers are the Local Hero Brands, strong regional brands and newly acquired products that successfully complement the existing product range.

Improving access to life-changing treatments for patients worldwide

Specialty Pharmaceuticals are medicines, that give patients access to innovative treatment options, especially for chronic, severe or rare diseases.

STADA’s Specialty portfolio includes innovative treatments for conditions such as Parkinson’s disease and a rare kidney disease, as well as a range of biologic medicines across uses in cancer, eyecare and autoimmune conditions.

Through partnerships, we are establishing a sustainable specialty pipeline to deliver on our purpose of “Caring for People’s Health as a Trusted Partner”.

Specialty Pharmaceuticals

Affordable generics have been the backbone of STADA since 1895

As a major player in the generics sector, we support patient care with affordable medicines. This is especially true in Europe, where STADA ranks as the fourth-largest manufacturer and supplier of generics in terms of sales.

Seven out of ten medicines prescribed in Europe are generic, but these account for only about 30% of all pharmaceutical expenditure.

Our purpose is ‘Caring for People’s Health as a Trusted Partner’

At STADA, this purpose unites all employees globally as a One STADA team with the aim of bringing health to society. It guides STADA's people in their day-to-day business –

and drives the company’s ambition to be the partner of choice in Consumer Healthcare, Generics and Specialty.

Our purpose